Grantham, Mayo, Van Otterloo & Co (GMO)’s SeaSpine Holdings Corporation Common Stock SPNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-10,500
Closed -$183K 971
2020
Q4
$183K Sell
10,500
-23,600
-69% -$359K ﹤0.01% 782
2020
Q3
$488K Sell
34,100
-31,100
-48% -$377K ﹤0.01% 624
2020
Q2
$683K Buy
65,200
+12,500
+24% +$128K 0.01% 591
2020
Q1
$431K Buy
+52,700
New +$694K ﹤0.01% 618

Other funds holding SPNE

Grantham, Mayo, Van Otterloo & Co (GMO)'s SPNE Position: Q1 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of SeaSpine Holdings Corporation Common Stock (SPNE) in Q1 2021, closing a stake of 10,500 shares — an estimated $183K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in SPNE in Q1 2020 and held it in 4 quarters. The position peaked at $683K in Q2 2020. 89 funds tracked by Wall St. Rank hold SPNE as of Q1 2021.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining SeaSpine Holdings Corporation Common Stock position as of Q1 2021 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 10,500 SeaSpine Holdings Corporation Common Stock shares in Q1 2021, an estimated $183K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in SeaSpine Holdings Corporation Common Stock in Q1 2020 and held it in 4 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s SeaSpine Holdings Corporation Common Stock position peaked at $683K in Q2 2020.
  • 89 funds tracked by Wall St. Rank held SeaSpine Holdings Corporation Common Stock as of Q1 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2021, filed 13 May 2021.